These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 21029596)

  • 41. Effects of mifepristone on the proliferation, apoptosis and cis-diamminedichloroplatinum sensitivity of cultured chemoresistant human ovarian cancer cells.
    Wang G; Shang HL; Xie Y; Xiao P; Li XJ; Lin TC; Li GY
    Chin Med J (Engl); 2005 Feb; 118(4):333-6. PubMed ID: 15740674
    [No Abstract]   [Full Text] [Related]  

  • 42. Cytotoxic effect of hyperthermia and chemotherapy with platinum salt on ovarian cancer cells: results of an in vitro study.
    Muller M; Chérel M; Dupré PF; Gouard S; Collet M; Classe JM
    Eur Surg Res; 2011; 46(3):139-47. PubMed ID: 21372578
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Proteasome inhibition leads to altered signaling in the proteome of cisplatin-resistant human ovarian carcinoma cell line.
    Duraj J; Pastorek M; Vitkovska J; Cholujova D; Gronesova P; Hunakova L; Sedlak J
    Neoplasma; 2013; 60(6):627-34. PubMed ID: 23906297
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Low-dose LBH589 increases the sensitivity of cisplatin to cisplatin-resistant ovarian cancer cells.
    Ma YY; Lin H; Moh JS; Chen KD; Wang IW; Ou YC; You YS; Lung CC
    Taiwan J Obstet Gynecol; 2011 Jun; 50(2):165-71. PubMed ID: 21791302
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Tannic acid, an inhibitor of poly(ADP-ribose) glycohydrolase, sensitizes ovarian carcinoma cells to cisplatin.
    Sun Y; Zhang T; Wang B; Li H; Li P
    Anticancer Drugs; 2012 Oct; 23(9):979-90. PubMed ID: 22785358
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Targeted proteasome inhibition by Velcade induces apoptosis in human mesothelioma and breast cancer cell lines.
    Wang Y; Rishi AK; Puliyappadamba VT; Sharma S; Yang H; Tarca A; Dou QP; Lonardo F; Ruckdeschel JC; Pass HI; Wali A
    Cancer Chemother Pharmacol; 2010 Aug; 66(3):455-66. PubMed ID: 19960346
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Ginkgo May Sensitize Ovarian Cancer Cells to Cisplatin: Antiproliferative and Apoptosis-Inducing Effects of Ginkgolide B on Ovarian Cancer Cells.
    Jiang W; Cong Q; Wang Y; Ye B; Xu C
    Integr Cancer Ther; 2014 May; 13(3):NP10-7. PubMed ID: 22505596
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Expression of connexin 43 in ovarian cancer and its relationship with chemoresistance].
    Li X; Liao QP
    Zhonghua Fu Chan Ke Za Zhi; 2009 Jan; 44(1):50-5. PubMed ID: 19563063
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Comparative evaluation of small-molecule chemosensitizers in reversal of cisplatin resistance in ovarian cancer cells.
    Yellepeddi VK; Vangara KK; Kumar A; Palakurthi S
    Anticancer Res; 2012 Sep; 32(9):3651-8. PubMed ID: 22993302
    [TBL] [Abstract][Full Text] [Related]  

  • 50. HIF-1α-induced autophagy contributes to cisplatin resistance in ovarian cancer cells.
    Long F; Liu W; Jia P; Wang H; Jiang G; Wang T
    Pharmazie; 2018 Sep; 73(9):533-536. PubMed ID: 30223937
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Primary ovarian cancer cells are sensitive to the proaptotic effects of proteasome inhibitors.
    Pasquini L; Petronelli A; Petrucci E; Saulle E; Mariani G; Scambia G; Benedetti-Panici P; Greggi S; Cognetti F; Testa U
    Int J Oncol; 2010 Mar; 36(3):707-13. PubMed ID: 20126991
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Liposomal cisplatin can overcome chemotherapy resistance of A2780 ovarian cancer cells by inducing the extrinsic apoptotic pathway.
    Stölting DP; Koch M; Wiese M; Royer HD; Bendas G
    Int J Clin Pharmacol Ther; 2014 Jan; 52(1):78-81. PubMed ID: 24290409
    [No Abstract]   [Full Text] [Related]  

  • 53. Modulation of cisplatin cytotoxicity due to its combination with bortezomib and the nature of its administration.
    Al-Eisawi Z; Beale P; Chan C; Yu JQ; Huq F
    Anticancer Res; 2011 Sep; 31(9):2757-62. PubMed ID: 21868517
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Malformin-A1 (MA1) Sensitizes Chemoresistant Ovarian Cancer Cells to Cisplatin-Induced Apoptosis.
    Abdullah N; Tamimi Y; Dobretsov S; Balushi NA; Alshekaili J; Al Balushi H; Al Kindi M; Hassan SI; Bahlani SA; Tsang BK; Burney IA
    Molecules; 2021 Jun; 26(12):. PubMed ID: 34199287
    [TBL] [Abstract][Full Text] [Related]  

  • 55. "Metabolic reprogramming" in ovarian cancer cells resistant to cisplatin.
    Montopoli M; Bellanda M; Lonardoni F; Ragazzi E; Dorigo P; Froldi G; Mammi S; Caparrotta L
    Curr Cancer Drug Targets; 2011 Feb; 11(2):226-35. PubMed ID: 21158717
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Advance in studies on molecular mechanisms of cisplatin resistance and intervention with traditional Chinese medicines].
    Liu L; Bian K
    Zhongguo Zhong Yao Za Zhi; 2014 Sep; 39(17):3216-20. PubMed ID: 25522600
    [TBL] [Abstract][Full Text] [Related]  

  • 57. New combination chemotherapy of cisplatin with an electron-donating compound for treatment of multiple cancers.
    Zhang Q; Lu QB
    Sci Rep; 2021 Jan; 11(1):788. PubMed ID: 33436996
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Enhancing proteasome-lnhibitor effect by functionalized gold nanoparticles.
    Coelho SC; Rocha S; Pereira MC; Juzenas P; Coelho MA
    J Biomed Nanotechnol; 2014 Apr; 10(4):717-23. PubMed ID: 24734524
    [TBL] [Abstract][Full Text] [Related]  

  • 59. GRP78 knockdown does not affect cytotoxicity of cisplatin in ovarian cancer cells.
    Kullmann M; Kotz S; Hellwig M; Kalayda GV; Metzger S; Jaehde U
    Int J Clin Pharmacol Ther; 2015 Dec; 53(12):1038-40. PubMed ID: 26521923
    [No Abstract]   [Full Text] [Related]  

  • 60. [Drug resistance in lung cancer].
    Szturmowicz M
    Pneumonol Alergol Pol; 2001; 69(1-2):102-10. PubMed ID: 11475553
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.